Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Stomach Neoplasms 83Pancreatic Neoplasms 26Esophageal Squamous Cell Carcinoma 10Esophageal Neoplasms 10Biliary Tract Neoplasms 10Colorectal Neoplasms 9Neoplasm Metastasis 7Nasopharyngeal Carcinoma 5Cholangiocarcinoma 5Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Recurrence 3Head and Neck Neoplasms 3Advanced Pancreatic Cancer 3Rectal Neoplasms 2NSCLC 2Locally Advanced Pancreatic Cancer 2Locally Advanced Gastric Cancer 2Gastrointestinal Neoplasms 2Gastric Cancer Peritoneal Metastases 2Advanced Non-Small Cell Lung Cancer 2Advanced Gastric Cancer 2Adenocarcinoma 2mCRC 1Surgically-Created Resection Cavity 1Stage IV Gastric Cancer With Metastasis 1Squamous Cell Carcinoma of Head and Neck 1Progression Free Survival 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pancreatic cancer, adult 1

Interventions

Docetaxel 5S 1 (combination) 2Carboplatin 2zimberelimab 1surufatinib 1quemliclustat 1pemigatinib 1nimotuzumab 1lorlatinib 1cemiplimab 1Vinorelbine 1Pemetrexed 1Paclitaxel 1Gene Expression Profiling 1Gemcitabine 1Erlotinib Hydrochloride 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Advanced Non-Small Cell Lung Cancer × S 1 (combination) × Clear all
NCT00651833 2024-09-03

Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer

Taiho Oncology, Inc.

Phase 2 Completed
60 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00652561 2024-09-03

Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer

Taiho Oncology, Inc.

Phase 2 Completed
57 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡